✦ LIBER ✦

Use of antibodies and immunoconjugates for the therapy of more accessible cancers

✍ Scribed by Robert M. Sharkey; David M. Goldenberg

Book ID: 113418267
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 774 KB
Volume: 60
Category: Article
ISSN: 0169-409X
DOI: 10.1016/j.addr.2008.04.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeted Therapy of Cancer: New Prospect

Targeted Therapy of Cancer: New Prospects for Antibodies and Immunoconjugates

✍ Dr. Robert M. Sharkey; Dr. David M. Goldenberg 📂 Article 📅 2006 🏛 American Cancer Society 🌐 English ⚖ 659 KB

The development of immunoconjugates for

The development of immunoconjugates for targeted cancer therapy

✍ Smaglo, Brandon G.; Aldeghaither, Dalal; Weiner, Louis M. 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 975 KB

Current applications of monoclonal antib

Current applications of monoclonal antibodies for the therapy of hematopoietic cancers

✍ David A. Scheinberg 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 803 KB

Recent trials of monoclonal antibodies in patients with leukemias or lymphomas have demonstrated the remarkable potency of these agents to kill tumor cells specifically and safely. New molecular biological and radiochemical techniques are also allowing rapid inroads into the remaining obstacles to t

The Use of Monoclonal Antibodies for the

The Use of Monoclonal Antibodies for the Diagnosis and Therapy of Bladder Cancer

✍ PAMELA J. RUSSELL; JANE PLOMLEY; D. RAGHAVAN 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 851 KB

Monoclonal antibodies in the study and t

Monoclonal antibodies in the study and therapy of hematopoietic cancers

✍ Dana C. Matthews; Franklin O. Smith; Irwin D. Bernstein 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Monoclonal antibodies in the study and t

Monoclonal antibodies in the study and therapy of hematopoietic cancers

✍ Dana C Matthews; Franklin O Smith; Irwin D Bernstein 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 904 KB

Recent advances utilizing monoclonal antibodies to phenotype acute leukemias have revealed no prognostic significance of the expression of lymphoid-associated antigens by acute myeloid leukemia blasts and conflicting results regarding 'biphenotypic' acute myeloid leukemia. Several studies treating p